Clinuvel Pharmaceuticals | CUV - Ebitda

Stock Price
11.40
Daily Change
0.18 1.60%
Monthly
-4.68%
Yearly
-0.18%
Q1 Forecast
11.42

Clinuvel Pharmaceuticals reported AUD27.55M in EBITDA for its fiscal semester ending in June of 2025.





Ebitda Change Date
Avita Medical AUD -21.9M 12.04M Jun/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesoblast USD -17.78M 17.03M Jun/2025
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024
Pacific Edge NZD -13.97M 332K Sep/2024
Paradigm Biopharmaceuticals AUD -5.86M 3.79M Dec/2024
PYC Therapeutics AUD -24.29M 1.3M Jun/2025
Telix Pharmaceuticals AUD 18.42M 14.82M Dec/2025